A review of global human infection with avian influenza and epidemiological characteristics

Abstract

Avian influenza virus is an influenza A virus, which generally spreads among birds, without direct infection of human. According to the pathogenicity to chicken or turkey, it is divided into high, medium and low/non pathogenic. When the virus gene recombination or mutation, it will get the ability to infect human. Additionally, avian influenza virus can also infect human directly, such as H5N1, H7N9, H5N6, H10N8 subtype. The cases of human infection with avian influenza reported frequently after the outbreak of human infection with H7N7 avian influenza in 1959, the first death case due to avian influenza virus infection causing respiratory disease was the outbreak of human infection with H5N1 in Hongkong in 1997. To date, human infection with avian influenza is a global public health problem. As avian influenza viruses perpetuated in their natural hosts, with their high genetic divergence, it would be precursor viruses even for pandemic potential. In the 20th century, four influenza pandemics were closely related to avian influenza viruses, avian is the natural host of the avian influenza virus, poultry carrying virus and dead/sick poultry infected with avian influenza virus are easier to spread virus to human, the main transmission routes are birds-human transmission (exposure to sick/dead poultry) and environment-human transmission (such as visit live poultry market). Poultries exposure and chronic medical condition are the main risk factors of human infection with avian influenza. The symptoms varies including ordinary influenza-like illness (ILI), conjunctivitis, arthritis, severe pneumonia, respiratory failure , shock and death. At present, the treatment of human infection with avian influenza includes antiviral treatment, symptomatic treatment, Chinese medicine treatment, but the most important therapy of human infection with avian influenza is the treatment of antiviral drugs (neuraminidase inhibitors), using high dose antiviral drugs in the early stage can significantly improve the survival rate. PCR and real-time PCR are the best methods for preliminary diagnosis of human infection with avian influenza. At the same time, the increase of serum antibody titer in acute stage or recovery stage can alao be confirmed. In addition, effective preventive measures (such as publicity and education, behavioral intervention and vaccination development and application) are the important means to protect human from avian influenza.